SGS Quay Pharma’s Post

Novo Nordisk's #Alhemo, intended for the prevention of bleeding in patients (adults & pediatrics over 12 years old) with #hemophilia A or B, is approved. It marks the first subcutaneous injection treatment of its kind. https://lnkd.in/gJsHpB3z

Elated to share that review article entitled "Pediatric drug delivery challenges: Enhancing compliance through age-appropriate formulations and safety measures" published in "Journal of drug delivery science and technology (JDDST), Q1 #elsevier #pediatrics #drugdelivery #agespecificformulations #impactfactor5.0 Cite score 7.3 https://lnkd.in/dzT7wCuU

Thoughts on this? >> FDA accepts BLA resubmission for pz-cel to treat recessive dystrophic epidermolysis bullosa - Contemporary Pediatrics >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #competitivemarketing #pharmaceutical #healthcare #pharma

Thoughts on this? >> FDA accepts BLA resubmission for pz-cel to treat recessive dystrophic epidermolysis bullosa - Contemporary Pediatrics >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #pharmaceutical #biotech #competitivemarketing

Great news for children affected by Central Precocious Puberty and their families! The phase III LIBELULA study has been launched to evaluate Debio 4326, a 12-month extended-release triptorelin formulation. Read more about Debio 4326 and how it could improve patient convenience and quality of life through reduced treatment frequency. #clinicaltrial #pediatric #patientcentricity #qualityoflife #triptorelin

A recent study published in the Journal of Clinical Pharmacology, reveals Lumosa's Naldebain effectively relieves postpartum pain after cesarean delivery while minimizing risk to breastfed infants. Remarkably, the measured relative infant dose (RID) was negligible (0.00%) as compared to the theoretical RID of 0.39%, indicating its potential as a safe and effective postpartum analgesic compatible with breastfeeding during the critical first week. Article link: https://lnkd.in/g7u74pYi #PainRelief #BreastFeeding #Analgesic #DrugDevelopment

Selecting the right excipients for pediatric dosage forms is crucial for safety and efficacy. In this article, Kevin Hughes, EMEA Regulatory Director at Colorcon, shares expert insights on excipient selection, highlighting key considerations for developing age-appropriate medications. A must-read for professionals in pediatric drug formulation - https://hubs.li/Q02NnVNl0 #Pharmaceuticals #Pediatrics #Excipients

Selecting the right excipients for pediatric dosage forms is crucial for safety and efficacy. In this article, Kevin Hughes, EMEA Regulatory Director at Colorcon® shares expert insights on excipient selection, highlighting key considerations for developing age-appropriate medications. A must-read for professionals in pediatric drug formulation - https://hubs.li/Q02NnVNl0 #Pharmaceuticals #Pediatrics #Excipients

🌐 Empower Your Clinical Decisions with Micromedex 🌐 Did you know that #Micromedex has evolved beyond a medication database to become a robust clinical decision support tool? With its comprehensive toxicology and pediatrics databases, healthcare professionals can access up-to-date information to manage the most critical cases effectively. 🩺💊 Whether you're treating pediatric patients or managing toxicological emergencies, Micromedex provides evidence-based guidance to improve patient outcomes. From detailed drug interactions to dosage monitoring, this tool is your partner in delivering safer and more precise care. 📊 With the integration of Dynamed’s resources, you now have access to an extensive database to understand disease mechanisms at every stage, including in neonatology. 👉 Contact us!! Discover how Micromedex can enhance your clinical practice today! #ClinicalDecisionSupport #HealthcareInnovation #Toxicology #Pediatrics #Neonatology #Dynamedex #HealthcareProfessionals #Pharmacology

🚀 Excited to share our recent #Editorial in Frontiers in Pediatrics, with colleagues karel allegaert, Elke Smits and Adriana Ceci, where we showcase the latest advancements in pediatric drug development as presented in the collection of impactful studies of the Research Topic "𝘚𝘶𝘱𝘱𝘰𝘳𝘵𝘪𝘯𝘨 𝘱𝘦𝘥𝘪𝘢𝘵𝘳𝘪𝘤 𝘥𝘳𝘶𝘨 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵: 𝘧𝘳𝘰𝘮 𝘣𝘢𝘴𝘪𝘤 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘵𝘰 𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘴𝘵𝘶𝘥𝘪𝘦𝘴 𝘢𝘯𝘥 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭 𝘢𝘥𝘷𝘢𝘯𝘤𝘦𝘮𝘦𝘯𝘵𝘴". 🤝 A special thanks to all authors & contributors for advancing the field of pediatric pharmacology with the aim of improving the therapeutic options of children. Read the editorial below👇 https://lnkd.in/dMaxZwdR